Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Non-nucleoside reverse transcriptase inhibitors

Non-nucleoside reverse transcriptase inhibitors

US Patent 8404856 · Granted Mar 26, 2013

Estimated economic value: $83,488,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

BRM/BRG1 inhibitors and uses thereof2025
Compounds and uses thereof2025
Protoporphyrinogen oxidase inhibitors2025
Tetragalnac and peptide containing conjugates and methods for delivery of oligon2025
Bicyclic carboxamides and methods of use thereof2025
PCSK9 antagonist compounds2025
PCSK9 antagonist compounds2024
Cyclic polypeptides for PCSK9 inhibition2024
Cyclic polypeptides for PCSK9 inhibition2024
Protoporphyrinogen oxidase inhibitors2024
Carbocyclic prolinamide derivatives2024
Protoporphyrinogen oxidase inhibitors2023